% | $
Quotes you view appear here for quick access.

Ligand Pharmaceuticals Incorporated Message Board

  • long_vrts2 long_vrts2 Oct 3, 2013 2:47 PM Flag

    Baze-CE approved:

    Oct 3 (Reuters) - U.S. health regulators approved Pfizer Inc's menopause drug Duavee, which the company hopes will reduce hot flashes with fewer side effects than older hormone-replacement therapies.
    The Food and Drug Administration said on Thursday it approved the drug to treat women with moderate to severe menopause symptoms and to prevent post-menopausal osteoporosis, a bone disease which can increase the risk of fractures.
    The drug, which Pfizer is developing with Ligand Pharmaceuticals Inc, combines bazedoxifene - which belongs to a class of drugs known as selective estrogen receptor modulators, or SERMS - and conjugated estrogens, which are derived from the urine of pregnant horses and contained in Pfizer's menopause drug Premarin.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
108.51+1.43(+1.34%)Dec 1 4:00 PMEST